Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Lee, Jung S ^a   Kim, Yoon T ^a   Jeon, Eun K ^a   Won, Hye S ^a   Cho, Young Seok ^a   Ko, Yoon H ^a  

^a Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

Antioxidant; Green tea extract; Oxaliplatin; Peripheral neuropathy

Indexed keywords

GREEN TEA EXTRACT; OXALIPLATIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; HOFFMANN REFLEX; LATENT PERIOD; MALE; NONHUMAN; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; RAT; SENSORY NERVE CONDUCTION; TREATMENT DURATION;

EID: 84864912725     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-124     Document Type: Article

References (24)

1. Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP. A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev 2008, 34:368-377. 10.1016/j.ctrv.2008.01.003, 18281158.
2. Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer 2005, 5(Suppl 1):38-46.
3. Lehky T, Leonard GD, Wilson RH, Grem JL, Floeter MK. Oxaliplatin induced neurotoxicity: Acute hyperexcitability and chronic neuropathy. Muscle Nerve 2004, 29:387-392. 10.1002/mus.10559, 14981738.
4. Park SB, Goldstein D, Lin CS, Krishnan AV, Friedlander ML, Kiernan MC. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 2009, 27:1243-1249. 10.1200/JCO.2008.19.3425, 19164207.
5. Cavaletti G, Tredici G, Petruccioli MG, Dondè E, Tredici P, Marmiroli P, Minoia C, Ronchi A, Bayssas M, Etienne GG. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer 2001, 37:2457-2463. 10.1016/S0959-8049(01)00300-8, 11720843.
6. Kann O, Kovacs R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007, 292:C641-C657.
7. Lersch C, Schmelz R, Eckel F, Erdmann J, Mayr M, Schulte-Frohlinde E, Quasthoff S, Grosskreutz J, Adelsberger H. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer. Clin Colorectal Cancer 2002, 2:54-58. 10.3816/CCC.2002.n.011, 12453338.
8. Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EG, Berger HM, Cleton FJ, Osanto S. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998, 9:1331-1337. 10.1023/A:1008407014084, 9932164.
9. Gamelin E, Gamelin L, Bossi L, Quasthoff S. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 2002, 29(5 Suppl 15):21-33. 10.1053/sonc.2002.35525, 12520481.
10. Krishnan AV, Goldstein D, Friedlander M, Kiernan MC. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve 2005, 32:51-60. 10.1002/mus.20340, 15880395.
11. Carozzi VA, Marmiroli P, Cavaletti G. The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity. Curr Cancer Drug Targets 2010, 10:670-682. 10.2174/156800910793605820, 20578989.
12. McWhinney SR, Goldberg RM, McLeod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 2009, 8:10-16. 10.1158/1535-7163.MCT-08-0840, 2651829, 19139108.
13. Nanjo F, Mori M, Goto K, Hara Y. Radical scavenging activity of tea catechins and their related compounds. Biosci Biotechnol Biochem 1999, 63:1621-1623. 10.1271/bbb.63.1621, 10610125.
14. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 2006, 78:2073-2080. 10.1016/j.lfs.2005.12.006, 16445946.
15. Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 2003, 21:927-931. 10.1200/JCO.2003.05.139, 12610195.
16. Joseph EK, Chen X, Bogen O, Levine JD. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 2008, 9:463-472. 10.1016/j.jpain.2008.01.335, 18359667.
17. Romeo L, Intrieri M, D'Agata V, Mangano NG, Oriani G, Ontario ML, Scapagnini G. The major green tea polyphenol,(-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr 2009, 28(Suppl 1):492S-499S.
18. De Grandis D. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review. CNS Drugs 2007, 21(Suppl 1):39-43.
19. Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G. Paclitaxel and cisplatin-induced neurotoxicity. Clin Cancer Res 2003, 9:5756-5767.
20. Helgren ME, Cliffer KD, Torrento K, Cavnor C, Curtis R, DiStefano PS, Wiegand SJ, Lindsay RM. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. J Neurosci 1997, 17:372-382.
21. Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain 2009, 132:271227-23.
22. Cascinu S, Catalano V, Cordella L, Labianca R, Giordani P, Baldelli AM, Beretta GD, Ubiali E, Catalano G. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2002, 20:3478-3483. 10.1200/JCO.2002.07.061, 12177109.
23. Gedlicka C, Scheithauer W, Schüll B, Kornek GV. Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. J Clin Oncol 2002, 20:3359-3361. 10.1200/JCO.2002.99.502, 12149316.
24. Sadzuka Y, Sugiyama T, Hirota S. Modulation of cancer chemotherapy by green tea. Clin Cancer Res 1998, 4:153-156.